The Ademi Firm is investigating Dun & Bradstreet (NYSE: DNB) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearlake.
In the transaction, Dun & Bradstreet shareholders will receive only $9.15 in cash for each share of common stock they own, with an equity value of $4.1 billion. Dun & Bradstreet insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Dun & Bradstreet by imposing a significant penalty if Dun & Bradstreet accepts a competing bid. We are investigating the conduct of the Dun & Bradstreet board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.